FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2951818441> ?p ?o ?g. }

• W2951818441 abstract "Over-expression of cyclooxygenase (COX)-2 promotes breast cancer progression by multiple mechanisms, including induction of stem-like cells (SLC). Combined gene expression and microRNA microarray analyses of empty vector vs COX-2- transfected COX-2 low MCF7 breast cancer cell line identified two COX-2-upregulated microRNAs, miR-526b and miR-655, both found to be oncogenic and SLC-promoting. Cytoplasmic Polyadenylation Element-Binding Protein 2 (CPEB2) was the single common target of both microRNAs, the functions of which remain controversial. CPEB2 has multiple isoforms (A-F), and paradoxically, a high B/A ratio was reported to impart anoikis-resistance and metastatic phenotype in triple- negative breast cancer cells. We tested whether CPEB2 is a tumor suppressor in mammary epithelial cells. We knocked-out CPEB2 in the non-tumorigenic mammary epithelial cell line MCF10A by CRISPR/Cas9-double nickase approach, and knocked-down CPEB2 with siRNAs in the poorly malignant MCF7 cell line, both lines being high CPEB2-expressing. The resultant phenotypes for oncogenity were tested in vitro for both lines and in vivo for CPEB2KO cells. Finally, CPEB2 expression was compared between human breast cancer and non-tumor breast tissues. CPEB2 (isoform A) expression was inversely correlated with COX-2 or the above microRNAs in COX-2-divergent breast cancer cell lines. CPEB2KO MCF10A cells exhibited oncogenic properties including increased proliferation, migration, invasion, EMT (decreased E-Cadherin, increased Vimentin, N-Cadherin, SNAI1, and ZEB1) and SLC phenotype (increased tumorsphere formation and SLC marker-expression). Tumor-suppressor p53 protein was shown to be a novel translationally-regulated target of CPEB2, validated with polysome profiling. CPEB2KO, but not wild-type cells produced lung colonies upon intravenous injection and subcutaneous tumors and spontaneous lung metastases upon implantation at mammary sites in NOD/SCID/IL2Rϒ-null mice, identified with HLA immunostaining. Similarly, siRNA-mediated CPEB2 knockdown in MCF7 cells promoted oncogenic properties in vitro. Human breast cancer tissues (n = 105) revealed a lower mRNA expression for CPEB2 isoform A and also a lower A/B isoform ratio than in non-tumour breast tissues (n = 20), suggesting that CPEB2A accounts for the tumor-suppressor functions of CPEB2. CPEB2, presumably the isoform A, plays a key role in suppressing tumorigenesis in mammary epithelial cells by repressing EMT, migration, invasion, proliferation and SLC phenotype, via multiple targets, including a newly-identified translational target p53." @default.
• W2951818441 created "2019-06-27" @default.
• W2951818441 creator A5004610314 @default.
• W2951818441 creator A5013772103 @default.
• W2951818441 creator A5018171790 @default.
• W2951818441 creator A5064145593 @default.
• W2951818441 creator A5073060923 @default.
• W2951818441 creator A5087321619 @default.
• W2951818441 date "2019-06-11" @default.
• W2951818441 modified "2023-09-25" @default.
• W2951818441 title "Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells" @default.
• W2951818441 cites W1548080449 @default.
• W2951818441 cites W1584400041 @default.
• W2951818441 cites W1828207058 @default.
• W2951818441 cites W1842994045 @default.
• W2951818441 cites W1966711656 @default.
• W2951818441 cites W1966841369 @default.
• W2951818441 cites W1971613589 @default.
• W2951818441 cites W1972962871 @default.
• W2951818441 cites W1976359234 @default.
• W2951818441 cites W1993253909 @default.
• W2951818441 cites W2000117535 @default.
• W2951818441 cites W2006185278 @default.
• W2951818441 cites W2011172287 @default.
• W2951818441 cites W2011960198 @default.
• W2951818441 cites W2012062654 @default.
• W2951818441 cites W2037513168 @default.
• W2951818441 cites W2037631027 @default.
• W2951818441 cites W2038153950 @default.
• W2951818441 cites W2053654678 @default.
• W2951818441 cites W2054531472 @default.
• W2951818441 cites W2061633610 @default.
• W2951818441 cites W2070732038 @default.
• W2951818441 cites W2082875440 @default.
• W2951818441 cites W2085316933 @default.
• W2951818441 cites W2088667095 @default.
• W2951818441 cites W2098412103 @default.
• W2951818441 cites W2102411854 @default.
• W2951818441 cites W2107996941 @default.
• W2951818441 cites W2111127316 @default.
• W2951818441 cites W2117692326 @default.
• W2951818441 cites W2127876070 @default.
• W2951818441 cites W2138670947 @default.
• W2951818441 cites W2150163671 @default.
• W2951818441 cites W2154589460 @default.
• W2951818441 cites W2161728771 @default.
• W2951818441 cites W2163898661 @default.
• W2951818441 cites W2165901622 @default.
• W2951818441 cites W2167380395 @default.
• W2951818441 cites W2168672165 @default.
• W2951818441 cites W2169752217 @default.
• W2951818441 cites W2230541670 @default.
• W2951818441 cites W2342398096 @default.
• W2951818441 cites W2345862441 @default.
• W2951818441 cites W2428522048 @default.
• W2951818441 cites W2472136603 @default.
• W2951818441 cites W2593403929 @default.
• W2951818441 cites W2606262935 @default.
• W2951818441 cites W2754572079 @default.
• W2951818441 cites W2781659973 @default.
• W2951818441 cites W2785714169 @default.
• W2951818441 cites W2889647842 @default.
• W2951818441 cites W4211224216 @default.
• W2951818441 doi "https://doi.org/10.1186/s12885-019-5771-5" @default.
• W2951818441 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6558855" @default.
• W2951818441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31185986" @default.
• W2951818441 hasPublicationYear "2019" @default.
• W2951818441 type Work @default.
• W2951818441 sameAs 2951818441 @default.
• W2951818441 citedByCount "16" @default.
• W2951818441 countsByYear W29518184412019 @default.
• W2951818441 countsByYear W29518184412020 @default.
• W2951818441 countsByYear W29518184412021 @default.
• W2951818441 countsByYear W29518184412022 @default.
• W2951818441 countsByYear W29518184412023 @default.
• W2951818441 crossrefType "journal-article" @default.
• W2951818441 hasAuthorship W2951818441A5004610314 @default.
• W2951818441 hasAuthorship W2951818441A5013772103 @default.
• W2951818441 hasAuthorship W2951818441A5018171790 @default.
• W2951818441 hasAuthorship W2951818441A5064145593 @default.
• W2951818441 hasAuthorship W2951818441A5073060923 @default.
• W2951818441 hasAuthorship W2951818441A5087321619 @default.
• W2951818441 hasBestOaLocation W29518184411 @default.
• W2951818441 hasConcept C104317684 @default.
• W2951818441 hasConcept C121608353 @default.
• W2951818441 hasConcept C145059251 @default.
• W2951818441 hasConcept C147447768 @default.
• W2951818441 hasConcept C152000582 @default.
• W2951818441 hasConcept C203014093 @default.
• W2951818441 hasConcept C204232928 @default.
• W2951818441 hasConcept C502942594 @default.
• W2951818441 hasConcept C530470458 @default.
• W2951818441 hasConcept C54009773 @default.
• W2951818441 hasConcept C54355233 @default.
• W2951818441 hasConcept C81885089 @default.
• W2951818441 hasConcept C86803240 @default.
• W2951818441 hasConcept C96232424 @default.
• W2951818441 hasConceptScore W2951818441C104317684 @default.
• W2951818441 hasConceptScore W2951818441C121608353 @default.
• W2951818441 hasConceptScore W2951818441C145059251 @default.

• next